About 3 to 6 % of all newborns require manual ventilation support to start breathing. Monivent has developed Neo100 which is a medical device providing continuous feedback on the volumes of air given to the baby during manual ventilation. To secure a robust manufacturing process to enable market launch, Monivent has chosen to collaborate with Cenova AB. Together, the two companies have combined their different core competences. Monivent with extensive product knowledge and Cenova with more than 40 years of experience in securing a robust and clean production environment. We all look forward to a long and successful collaboration many years to come.